CAMLINFINE103.71

Camlin Fine Sciences Limited

· Chemicals
AnnualQuarterly₹ CrorePeersCLEANDEEPAKNTRBAYERCROPTIRUMALCHMATULSHKPAUSHAKLTDANURASMcap ₹1,992 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,613.11,666.51,723.31,861.7
Other Income15.614.528.832.8
Total Income1,628.61,681.01,752.11,894.5
Expenses
+ Cost of Materials Consumed746.6786.3823.3909.8
+ Purchases of Stock-in-Trade114.3117.588.669.6
+ Changes in Inventories52.7-54.510.639.8
+ Employee Benefit Expense178.7192.3243.9263.4
+ Finance Costs60.399.972.974.2
+ Depreciation & Amortisation78.663.870.975.5
+ Other Expenses446.8416.9450.1493.2
Total Expenses1,678.11,622.11,760.31,925.6
EBITDA73.9208.1106.985.9
EBIT-4.7144.336.010.4
Profit
PBT before Exceptional Items-49.458.8-8.2-31.1
+ Exceptional Items-49.8-9.8-25.5-36.6
Pretax Income-99.249.0-33.6-67.6
+ Current Tax24.942.117.915.8
+ Deferred Tax-19.2-42.1-18.4-16.5
Tax Expense5.60.1-0.5-0.7
+ Share of Associates & JVs0.00.41.72.2
Net Income-104.9-158.123.50.6
+ Net Income — Continuing Ops-104.949.0-33.2-66.9
+ Net Income — Discontinued Ops0.0-207.555.165.3
+ Other Comprehensive Income18.0-12.23.48.8
Total Comprehensive Income-86.9-170.427.09.4
Net Income to Common-92.8-139.027.65.9
Minority Interest-12.1-19.1-4.1-5.3
Per Share
Basic EPS-5.58-8.031.460.27
Diluted EPS-5.50-7.941.420.22
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.0-207.555.265.5
+ Tax — Discontinued Operations0.00.00.20.2
Other Comprehensive Income — detail
+ Other Comprehensive Income-12.23.48.8
+ Items NOT to be Reclassified to P&L-0.1-0.1-0.1-0.3
+ Tax on Items NOT to be Reclassified-0.0-0.1-0.1
+ Tax on Items NOT to be Reclassified — alt tag-0.0
+ Items to be Reclassified to P&L18.0-12.41.08.5
+ Tax on Items to be Reclassified-0.2-2.5-0.5
+ Tax on Items to be Reclassified — alt tag0.0
Comprehensive Income — Owners of Parent18.4-151.334.718.8
Comprehensive Income — Non-controlling Interests-0.4-19.1-7.8-9.5
Per Share — as-filed variants
Basic EPS — Continuing Operations-5.582.89-1.59-3.00
Diluted EPS — Continuing Operations-5.502.86-1.59-3.00
Basic EPS — Discontinued Operations0.00-10.923.053.27
Diluted EPS — Discontinued Operations0.00-10.803.013.22
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit699.4817.3800.9842.5
Gross Margin %43.3649.0446.4745.25
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)-49.458.8-8.2-31.1
− Exceptional Items (reconciliation)-49.8-9.8-25.5-36.6
Net Income Adj (tax-effected)-55.1-148.348.736.8
EPS Adj-2.93-7.533.0216.48
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.00
Filed Debt Equity0.000.72
Filed Dscr0.000.01
Paid Up Equity Capital16.718.819.219.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.